Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJ4AB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,468
Award facts
- Contract value 100% obligated
- $43,467.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $43,467.51 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on August 15, 2025, with completion scheduled for August 18, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for delivery to the place of performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and established federal contractor specializing in healthcare solutions for military and veteran healthcare systems. The company's contract portfolio with the DLA demonstrates extensive capabilities in delivering both brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This specific award for Dupixent, a prescription biologic used to treat atopic dermatitis and other allergic conditions, reflects the company's continued role as a critical supplier within the federal medical supply chain and its ability to fulfill specialized pharmaceutical procurement requirements on a competitive basis.
Quick answers
Who was awarded contract SPE2DB25FJ4AB?
SPE2DB25FJ4AB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FJ4AB worth?
The government has obligated $43,468 on SPE2DB25FJ4AB.
Is contract SPE2DB25FJ4AB an order under another contract?
Yes. SPE2DB25FJ4AB is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4AB competed?
The extent of competition for SPE2DB25FJ4AB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award